Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from an analysis of 160 real-world patients with ...
Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
Get key insights from Myriad Genetics’ Q3 2025 earnings call, growth strategies, financial outlook, and new product launches.
Thank you, Sabrina, and good morning, everyone. The third quarter was another exceptional quarter for GeneDx. Achieving that vision requires a fast-growing, disciplined, profitable business that ...
The immune/tumor microenvironment significantly influences cancer progression and the efficacy of immunotherapeutic ...
Amid unprecedented scientific progress in oncology, a growing body of evidence reveals a parallel and profound crisis in the human experience of cancer care. Despite overall survival outcomes ...
The Cool Down on MSN
Researchers issue warning about overlooked hazard that can increase cancer risk: 'Harmful biological effects'
These particles don't just sit harmlessly in the body; they trigger chronic inflammation, oxidative stress, and DNA damage. As the study put it, "These particles induce harmful biological effects," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback